These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1256132)

  • 21. Your CE topic (No. 33). Pharmacologic management of cystic fibrosis.
    Waite WW
    J Pract Nurs; 1988 Sep; 38(3):19-29. PubMed ID: 3418545
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice.
    Littlewood JM
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S56-62; discussion S59-62. PubMed ID: 8869184
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnosis and treatment of exocrine pancreatic insufficiency in mucoviscidosis].
    Shmerling DH
    Z Allgemeinmed; 1972 Aug; 48(24):1080-4. PubMed ID: 4649650
    [No Abstract]   [Full Text] [Related]  

  • 25. Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into the future.
    George DE; Mangos JA
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S49-57. PubMed ID: 3042940
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of L-arginine and sodium bicarbonate in the treatment of malabsorption due to cystic fibrosis.
    Kattwinkel J; Agus SG; Taussig LM; Di Sant'Agnese PA; Laster L
    Pediatrics; 1972 Jul; 50(1):133-7. PubMed ID: 5038088
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastrointestinal manifestations of cystic fibrosis.
    Riedel BD
    Pediatr Ann; 1997 Apr; 26(4):235-41. PubMed ID: 9114442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis.
    Nouisa-Arvanitakis S; Stapleton FB; Linshaw MA; Kennedy J
    J Pediatr; 1977 Feb; 90(2):302-5. PubMed ID: 830926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis of the pancreas in adolescence and adulthood.
    Gracey M; Anderson CM
    Australas Ann Med; 1969 May; 18(2):91-101. PubMed ID: 4895786
    [No Abstract]   [Full Text] [Related]  

  • 30. Dietary intake of healthy children with cystic fibrosis compared with normal control children.
    Tomezsko JL; Stallings VA; Scanlin TF
    Pediatrics; 1992 Oct; 90(4):547-53. PubMed ID: 1408508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of digestive insufficiency in cystic fibrosis].
    Auricchio S
    Pediatria (Napoli); 1981 Sep; 89(3):305-14. PubMed ID: 7050880
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperuricosuria in cystic fibrosis patients treated with pancreatic enzyme supplements. A study of 16 patients in Israel.
    Sack J; Blau H; Goldfarb D; Ben-Zaray S; Katznelson D
    Isr J Med Sci; 1980 Jun; 16(6):417-9. PubMed ID: 6901713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mucoviscidosis, current views on therapy].
    Rossi E; Hagmann R
    Schweiz Med Wochenschr; 1971 Mar; 101(12):413-8. PubMed ID: 5559405
    [No Abstract]   [Full Text] [Related]  

  • 35. [Functional examination of the lungs in evaluating the effect of respiratory rehabilitation and mucolytics in cystic fibrosis].
    Zapletal A; Vávrová V; Stefanová J; Horák J; Samánek M
    Cesk Pediatr; 1983 Sep; 38(9):519-24. PubMed ID: 6640752
    [No Abstract]   [Full Text] [Related]  

  • 36. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uses and abuses of enzyme therapy in cystic fibrosis.
    Durie P; Kalnins D; Ellis L
    J R Soc Med; 1998; 91 Suppl 34(Suppl 34):2-13. PubMed ID: 9709382
    [No Abstract]   [Full Text] [Related]  

  • 38. Potato crisps without pancreatic extracts supplements: a potential cause of the distal intestinal obstruction in cystic fibrosis.
    Kopriva F; Michálková K; Zápalka M; Malý J
    Eur J Pediatr; 2007 Sep; 166(9):969-70. PubMed ID: 17124589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The treatment of mucoviscidosis (pancreatic fibrosis, cystic fibrosis)].
    Kerrebijn KF
    Ned Tijdschr Geneeskd; 1972 Nov; 116(46):2100-5. PubMed ID: 4653498
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP; Dain MP; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.